By Pearson correlation analysis, we found that the expression of CHK1 in patients with AML was positively correlated with the level of FLT3-ITD (r = 0.512, p < 0.001, Fig. 2C). This evidence concerns the gene CHEK1 and acute myeloid leukemia.